Tofacitinib versus Biologic Treatments in Moderate-to-Severe Rheumatoid Arthritis Patients Who Have Had an Inadequate Response to Nonbiologic DMARDs: Systematic Literature Review and Network Meta-Analysis
about
Tofacitinib: A Review in Rheumatoid Arthritis.The Role of High-Mobility Group Box-1 and Its Crosstalk with Microbiome in Rheumatoid Arthritis.European perspective on the management of rheumatoid arthritis: clinical utility of tofacitinib.Micro - Focused Phototherapy Associated To Janus Kinase Inhibitor: A Promising Valid Therapeutic Option for Patients with Localized Vitiligo.
P2860
Tofacitinib versus Biologic Treatments in Moderate-to-Severe Rheumatoid Arthritis Patients Who Have Had an Inadequate Response to Nonbiologic DMARDs: Systematic Literature Review and Network Meta-Analysis
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 March 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Tofacitinib versus Biologic Tr ...... view and Network Meta-Analysis
@en
Tofacitinib versus Biologic Tr ...... iew and Network Meta-Analysis.
@nl
type
label
Tofacitinib versus Biologic Tr ...... view and Network Meta-Analysis
@en
Tofacitinib versus Biologic Tr ...... iew and Network Meta-Analysis.
@nl
prefLabel
Tofacitinib versus Biologic Tr ...... view and Network Meta-Analysis
@en
Tofacitinib versus Biologic Tr ...... iew and Network Meta-Analysis.
@nl
P2093
P2860
P356
P1476
Tofacitinib versus Biologic Tr ...... view and Network Meta-Analysis
@en
P2093
Charles Makin
David Gruben
Robert A Gerber
Tatjana Lukic
P2860
P304
P356
10.1155/2017/8417249
P577
2017-03-09T00:00:00Z